Comerica Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

Comerica Bank’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$622K	Sell	26,637 -50,262	-65%	-$1.12M	﹤0.01%	1765
2025 Q3	$1.51M	Buy	76,899 +31,719	+70%	+$652K	0.01%	1303
2025 Q2	$980K	Buy	45,180 +2,261	+5%	+$53.4K	﹤0.01%	1540
2025 Q1	$1.04M	Buy	42,919 +397	+0.9%	+$8.94K	﹤0.01%	1480
2024 Q4	$887K	Buy	42,522 +312	+0.7%	+$6.7K	﹤0.01%	1619
2024 Q3	$839K	Buy	42,210 +863	+2%	+$16K	﹤0.01%	1637
2024 Q2	$640K	Sell	41,347 -9,810	-19%	-$153K	﹤0.01%	1725
2024 Q1	$815K	Buy	51,157 +4,377	+9%	+$66K	﹤0.01%	1647
2023 Q4	$786K	Buy	46,780 +1,014	+2%	+$13.9K	﹤0.01%	1643
2023 Q3	$535K	Buy	+45,766	New	+$612K	﹤0.01%	1758
2022 Q4	$1.15M	Sell	56,885 -15,835	-22%	-$244K	0.01%	1375
2022 Q3	$1.02M	Buy	+72,720	New	+$862K	0.01%	1450

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Comerica Bank's CPRX Position: Q4 2025 in Review

Comerica Bank reduced its Catalyst Pharmaceutical (CPRX) stake by 65% in Q4 2025, selling an estimated $1.12M and leaving 26,637 shares worth $622K. The position accounts for ﹤0.01% of the portfolio, ranked #1765.

Comerica Bank first reported a position in CPRX in Q3 2022 and has held it in 12 quarters since. The position peaked at $1.51M in Q3 2025. 373 funds tracked by Wall St. Rank hold CPRX as of Q4 2025.

Comerica Bank held 26,637 shares of Catalyst Pharmaceutical worth $622K as of Q4 2025.
Comerica Bank sold 50,262 Catalyst Pharmaceutical shares in Q4 2025, an estimated $1.12M.
Catalyst Pharmaceutical made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1765 holding.
Comerica Bank first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 12 quarters since.
Comerica Bank's Catalyst Pharmaceutical position peaked at $1.51M in Q3 2025.
373 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.